HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert S Rosenson Selected Research

oxidized low density lipoprotein

7/2022Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy.
4/2022Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period.
10/2021The Projected Impact of Population-Wide Achievement of LDL Cholesterol <70 mg/dL on the Number of Recurrent Events Among US Adults with ASCVD.
6/2021Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US.
1/2021Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON.
1/2021Existing and emerging therapies for the treatment of familial hypercholesterolemia.
1/2021Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans.
1/2021Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction.
1/2021What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD Registry.
9/2020Low-density lipoprotein cholesterol levels among individuals experiencing statin-associated symptoms: Data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert S Rosenson Research Topics

Disease

72Cardiovascular Diseases (Cardiovascular Disease)
12/2022 - 07/2002
47Coronary Disease (Coronary Heart Disease)
01/2022 - 01/2002
30Atherosclerosis
11/2021 - 01/2002
27Myocardial Infarction
10/2022 - 07/2002
26Dyslipidemias (Dyslipidemia)
04/2022 - 07/2002
21Type 2 Diabetes Mellitus (MODY)
01/2021 - 07/2002
20Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014 - 11/2003
14Hypercholesterolemia
04/2022 - 11/2003
13Stroke (Strokes)
01/2022 - 09/2007
13Acute Coronary Syndrome
10/2018 - 12/2002
11Inflammation (Inflammations)
10/2021 - 07/2003
9COVID-19
12/2022 - 10/2020
9Coronary Artery Disease (Coronary Atherosclerosis)
12/2022 - 07/2002
8Hyperlipidemias (Hyperlipidemia)
01/2021 - 02/2008
8Insulin Resistance
09/2011 - 06/2004
7Hypertriglyceridemia
01/2021 - 04/2002
7Muscular Diseases (Myopathy)
01/2018 - 03/2004
6Ischemic Stroke
01/2022 - 05/2008
6Diabetes Mellitus
07/2019 - 04/2002
6Heart Failure
10/2015 - 07/2003
5Chronic Renal Insufficiency
09/2021 - 01/2019
5Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2021 - 01/2017
5Rhabdomyolysis
07/2019 - 03/2014
5Myalgia
01/2018 - 03/2014
5Vascular Diseases (Vascular Disease)
01/2018 - 07/2005
5Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
01/2018 - 02/2016
4Critical Illness (Critically Ill)
08/2021 - 04/2006
3Homozygous Familial Hypercholesterolemia
01/2021 - 01/2020
3Body Weight (Weight, Body)
12/2020 - 08/2002
3Peripheral Arterial Disease
01/2020 - 01/2017
3Sepsis (Septicemia)
01/2019 - 04/2006
3Hypertension (High Blood Pressure)
09/2011 - 07/2003
3Unstable Angina
09/2010 - 07/2002
3Obesity
11/2008 - 07/2003
2Confusion (Bewilderment)
01/2020 - 05/2006
2Atherosclerotic Plaque (Atheroma)
09/2012 - 12/2002
2Infarction (Infarctions)
02/2011 - 07/2003

Drug/Important Bio-Agent (IBA)

85Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2022 - 01/2002
51oxidized low density lipoproteinIBA
07/2022 - 12/2002
44LipidsIBA
12/2022 - 11/2002
44LDL CholesterolIBA
07/2022 - 11/2003
28Lipoproteins (Lipoprotein)IBA
11/2021 - 01/2002
28HDL CholesterolIBA
10/2021 - 07/2002
24Triglycerides (Triacylglycerol)IBA
11/2021 - 04/2002
16CholesterolIBA
01/2022 - 04/2005
16Biomarkers (Surrogate Marker)IBA
01/2019 - 08/2005
14LDL Lipoproteins (beta Lipoproteins)IBA
12/2020 - 07/2002
13Ezetimibe (Zetia)FDA Link
10/2021 - 03/2014
12evolocumabIBA
04/2022 - 03/2014
11Proprotein Convertase 9IBA
10/2021 - 06/2016
10Atorvastatin (Lipitor)FDA Link
01/2017 - 10/2007
10Secretory Phospholipases A2IBA
01/2014 - 02/2009
9HDL LipoproteinsIBA
10/2021 - 05/2005
9ApolipoproteinsIBA
01/2021 - 02/2008
91-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
01/2018 - 02/2008
8Glucose (Dextrose)FDA LinkGeneric
10/2017 - 09/2004
8Rosuvastatin Calcium (Crestor)FDA Link
01/2017 - 11/2003
8Fenofibrate (CiL)FDA LinkGeneric
06/2014 - 08/2007
8Phospholipases (Phospholipase)IBA
03/2014 - 02/2009
8varespladib methylIBA
12/2012 - 02/2009
7Fibric Acids (Fibrates)IBA
10/2015 - 09/2004
6EnzymesIBA
07/2019 - 07/2003
5CytokinesIBA
11/2021 - 02/2005
5Insulin (Novolin)FDA Link
10/2020 - 09/2004
5Pharmaceutical PreparationsIBA
01/2020 - 02/2008
5fenofibric acidFDA Link
06/2014 - 12/2010
5Colesevelam Hydrochloride (Welchol)FDA Link
06/2014 - 04/2006
4Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
03/2020 - 11/2002
4Angiotensin Receptor AntagonistsIBA
03/2020 - 07/2003
4Niacin (Nicotinic Acid)FDA LinkGeneric
10/2015 - 07/2002
4IsoenzymesIBA
04/2011 - 11/2009
4C-Reactive ProteinIBA
09/2010 - 07/2002
3Heparin (Liquaemin)FDA LinkGeneric
08/2021 - 10/2020
3alirocumabIBA
01/2020 - 02/2017
3PCSK9 InhibitorsIBA
07/2019 - 01/2018
3Hypolipidemic Agents (Antihyperlipidemics)IBA
12/2018 - 10/2016
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2018 - 11/2002
3Metformin (Glucophage)FDA LinkGeneric
06/2014 - 09/2004
3varespladibIBA
01/2014 - 11/2009
3darapladibIBA
06/2013 - 09/2012
3Oxidoreductases (Dehydrogenase)IBA
02/2011 - 01/2002
3Fatty Acids (Saturated Fatty Acids)IBA
08/2009 - 08/2007
3Fibrinogen (Factor I)FDA Link
07/2003 - 04/2002
3Pravastatin (Pravachol)FDA LinkGeneric
12/2002 - 01/2002
2Lipoprotein(a)IBA
01/2022 - 01/2021
2Apolipoproteins B (ApoB)IBA
01/2021 - 02/2011
2evinacumabIBA
12/2020 - 01/2020
2Monoclonal AntibodiesIBA
01/2020 - 06/2016
2TicagrelorIBA
01/2019 - 10/2018
2Gemfibrozil (Lopid)FDA LinkGeneric
12/2018 - 02/2008
2Clopidogrel (Plavix)FDA Link
10/2018 - 02/2011
2Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2016 - 02/2015
2Bile Acids and Salts (Bile Acids)IBA
10/2015 - 07/2012
2CalciumIBA
07/2015 - 02/2011
2Phospholipases A2 (Phospholipase A2)IBA
12/2012 - 12/2010
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2012 - 02/2007
2ErythropoietinFDA Link
02/2011 - 04/2010

Therapy/Procedure

84Therapeutics
12/2022 - 07/2002
4Drug Therapy (Chemotherapy)
05/2010 - 05/2005
3Secondary Prevention
07/2015 - 11/2002